If you liked this article you might like

Former Dendreon CEO Mitch Gold Returns to Public Biotech Stage with Cancer Immunotherapy Merger
These 5 Stocks Under $10 Could Make You a Lot of Money
7 Stocks Under $10 Making Big Up Moves
7 Stocks Under $10 to Trade for Big Post-Brexit Gains